Exploring Three Indian Exchange Stocks Estimated To Be Up To 43.8% Below Intrinsic Value

In This Article:

The Indian market has shown robust growth, climbing 1.2% in the past week and achieving a 45% increase over the last year, with earnings expected to grow by 16% annually. In this thriving environment, identifying stocks that are trading below their intrinsic value could present opportunities for investors seeking potential gains.

Top 10 Undervalued Stocks Based On Cash Flows In India

Name

Current Price

Fair Value (Est)

Discount (Est)

HEG (NSEI:HEG)

?2084.15

?3283.63

36.5%

IOL Chemicals and Pharmaceuticals (BSE:524164)

?412.45

?636.71

35.2%

Updater Services (NSEI:UDS)

?314.10

?539.26

41.8%

Vedanta (NSEI:VEDL)

?451.40

?748.67

39.7%

Rajesh Exports (NSEI:RAJESHEXPO)

?309.95

?506.28

38.8%

Strides Pharma Science (NSEI:STAR)

?935.00

?1664.05

43.8%

Mahindra Logistics (NSEI:MAHLOG)

?523.65

?901.85

41.9%

Delhivery (NSEI:DELHIVERY)

?382.05

?738.99

48.3%

PVR INOX (NSEI:PVRINOX)

?1412.20

?2539.84

44.4%

Godrej Properties (NSEI:GODREJPROP)

?3362.65

?5576.49

39.7%

Click here to see the full list of 20 stocks from our Undervalued Indian Stocks Based On Cash Flows screener.

Let's dive into some prime choices out of from the screener.

Godrej Properties

Overview: Godrej Properties Limited operates in real estate construction and development across India, with a market capitalization of approximately ?935.01 billion.

Operations: The company generates revenue primarily from real estate development, amounting to ?29.95 billion, and a smaller segment in hospitality, which contributes ?0.41 billion.

Estimated Discount To Fair Value: 39.7%

Godrej Properties, trading at ?3362.65, significantly below its fair value of ?5576.49, shows potential as an undervalued stock based on cash flows. Despite challenges in debt coverage by operating cash flow, the company has demonstrated robust earnings growth at 35.76% per year and revenue growth forecasted at 31.6% annually, outpacing the Indian market significantly. Recent acquisitions in Bengaluru and Pune with substantial revenue potentials (INR 12 billion and INR 18 billion respectively) underscore aggressive expansion and promising future income streams.

NSEI:GODREJPROP Discounted Cash Flow as at Jul 2024
NSEI:GODREJPROP Discounted Cash Flow as at Jul 2024

Strides Pharma Science

Overview: Strides Pharma Science Limited, operating globally including in Africa, Australia, North America, Europe, Asia, and India, focuses on developing, manufacturing, and selling pharmaceutical products with a market capitalization of approximately ?85.94 billion.